Electrocardiographic Markers of Founder Mutations in Arrhythmogenic Cardiomyopathy

Introduction:
Arrhythmogenic cardiomyopathy (ACM) is a rare but serious condition linked to specific genetic mutations, such as TMEM43 and phospholamban mutations. These mutations can significantly impact heart function, often leading to sudden cardiac death or heart failure. Understanding electrocardiographic (ECG) criteria is crucial for early detection and management.

Key Findings from the Study

  • Founder Mutations & Their Impact:
    • TMEM43 (p.S358L) mutation is highly aggressive, requiring primary prophylactic implantable cardioverter defibrillator (ICD) implantation in men and women over 30.
    • Phospholamban p.Arg14del mutation leads to biventricular cardiomyopathy and is associated with progressive heart failure.Electrocardiographic
    • Poor R-wave progression in right precordial leads.
    • T-wave inversions in lateral leads (common in TMEM43 mutations).
    • Low voltage ECG and right bundle branch block (common in phospholamban mutations).
    • Presence of epsilon waves in right precordial leads and lead aVR.

Broader Implications in Cardiovascular Medicine

Where to Read the Full Study

Further Reading & Related Studies

  • Explore studies on implantable cardioverter defibrillators (ICDs) for arrhythmia management.

Join the Discussion!

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.